Genotyping companies identify genetic variants within individuals, populations and biological samples. Their technologies support biomedical research, diagnostics, breeding programmes, pharmacogenomics and population-scale genetic studies.
This category includes companies working on:
Browse 35 UK genotyping companies below.
Molecular diagnostic kits and genomic services for clinical laboratories
Yourgene Health is a molecular diagnostics company developing, manufacturing and commercialising IVD reagent kits and genomic services for reproductive health, precision medicine and infectious disease. Its product portfolio includes NGS-based non-invasive prenatal testing kits, cystic fibrosis screening assays,…
Targeted transcriptomic sequencing services for diagnostics and drug discovery
BioClavis is a genomics R&D and services laboratory leveraging their targeted RNA sequencing platform for high-throughput transcriptomic and biomarker analysis. The platform enables customisable gene expression profiling from crude cell lysates and archival FFPE tissue without nucleic acid purification, making it…
Molecular serotyping microarrays and surveillance services for vaccine pathogens
BUGS Bioscience is a not-for-profit biotechnology spin-out of the Bacterial Microarray Group at St George's, University of London. The company develops and provides molecular serotyping microarray platforms and associated genomic surveillance services for vaccine-preventable bacterial pathogens, including…
Animal genetics company applying genomics and gene editing to livestock
Genus plc specialises in the genetic improvement of livestock through genomic selection and gene editing. Its commercial divisions supply semen and embryos from elite cattle and genetically superior breeding pigs to producers globally. Its R&D programme applies CRISPR-based precision breeding to improve disease…
Genetic insights to guide drug discovery and development
Sequoia Genetics is a contract research organisation applying human genetic data to inform drug discovery and clinical development. The company works with pharmaceutical companies, biotechnology firms, investors, and academic institutions to generate and interpret genetic insights that can guide target validation and…
Molecular diagnostic assay development for oncology biomarkers
APIS Assay Technologies is a molecular diagnostics company developing and commercialising genomic assays for oncology and personalised medicine. The company combines an in-house biomarker research programme with contract assay development services, using PCR, digital PCR, and multi-omics platforms to translate…
Somatic genomics for genetically validated drug target discovery
Quotient Therapeutics is a biotechnology company developing medicines from genetic differences between cells within the same person. Its somatic genomics platform combines sensitive DNA sequencing, cell analysis and computational biology to identify mutations linked to disease resistance or susceptibility. These…
Applied genetics and genomics services and distribution for DNA testing
Biosecure ID is a contract research organisation providing professional services and integrated workflow solutions for applied genetics and genomics testing. The company supports academic, clinical, and forensic laboratories with workflow validation, implementation, and turnkey project delivery across NGS, STR…
Point-of-care pharmacogenetic testing platform for emergency healthcare
Genedrive is a molecular diagnostics company developing point-of-need pharmacogenetic tests that identify genetic variants to guide safer, more personalised medicine decisions in time-critical emergency care. Its flagship products, developed and validated with NHS partners, include a neonatal test preventing…
Multiplex PCR and NGS diagnostics for cancer and infection
GeneFirst is a molecular diagnostics company developing multiplex PCR assays and next-generation sequencing technologies for cancer screening, precision oncology and infectious disease testing. Its Papilloplex assays detect high-risk human papillomavirus DNA or E6/E7 mRNA. The XCeloSeq platform provides library…
Inkjet microarray printing instruments and contract array services
Arrayjet is a manufacturer of inkjet-based microarray printing instruments and a provider of contract array research and manufacturing services. The company's patented non-contact dispensing platform prints proteins, antibodies, nucleic acids, and small molecules onto solid substrates for applications including…
DNA identification and STR-based cell-line authentication services
NorthGene is Biofortuna's genetic testing brand, operating from accredited laboratories in Deeside, Wales. Its services include DNA relationship and forensic identification testing, plus short tandem repeat profiling for cell-line authentication. Research customers can request mycoplasma detection, culture mixture…
Global leader in next-generation sequencing and genomic analysis
Illumina is a US-headquartered life science company and the dominant provider of next-generation sequencing platforms and array-based genotyping tools. Its UK operations are based at Granta Park in Cambridge, serving as its primary European research and commercial hub. Illumina's technologies underpin applications in…
AI platform combining retinal imaging and genomics for inherited eye disease diagnosis
Eye2Gene is an AI-powered precision ophthalmology platform combining retinal imaging with genomic analysis to accelerate diagnosis of inherited retinal diseases. Using a neural network ensemble trained on tens of thousands of multimodal retinal scans, the platform predicts the likely causative gene behind a patient's…
Digital clinical implementation platform bringing genomics into everyday healthcare
Fava Health is a health technology company helping deliver genomics at scale by integrating genetic insights into clinical systems and workflows. The company builds design-led digital solutions that support clinical decision-making within existing NHS infrastructure, alongside strategic consultancy for life sciences…